
LINK . SPRINGER . COM {
}
Title:
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer | Gastric Cancer
Description:
Background Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Methods Medical records of AGC patients who were treated with irinotecan monotherapy as salvage-line treatment in six institutions from 2007 to 2014 were reviewed. Results A total of 146 patients had prior fluoropyrimidine and taxane therapies, and 75.3% had prior platinum therapy. The median age was 66 (range 27–81) years, and 102 males (69.9%) were included. Performance status (PS) was 0/1/2/3 in 53/70/19/4 patients. Eighty-nine patients (61.0%) had two or more metastatic sites. Irinotecan monotherapy as 3rd-/4th-line therapy was performed in 135/11 (92.5%/7.5%). The median number of administrations was 4 (range 1–62). Forty-six patients (31.5%) required initial dose reduction at the physician’s discretion. The overall response rate was 6.8%, and the disease control rate was 43.1%. The median PFS was 3.19 months [95% confidence interval (CI) 2.30–4.08 months], and the median OS was 6.61 months (95% CI 5.94–7.28 months). Grade 3/4 adverse events were hematological toxicity (46 patients, 31.5%) and non-hematological toxicity (50 patients, 34.2%). Hospitalization due to adverse events was required in 31 patients (21.2%). Patients with relative dose intensity (RDI) less than 80% showed similar survival to those with RDI 80% or higher. Conclusions Irinotecan monotherapy was relatively safely performed as salvage-line treatment for AGC in Japanese clinical practice. Careful patient selection and intensive modification of the dose of irinotecan might possibly be associated with favorable survival.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Health & Fitness
- Insurance
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {🔍}
patients, irinotecan, dose, treatment, monotherapy, months, study, cancer, group, chemotherapy, gastric, median, agc, survival, treated, article, pfs, initial, advanced, therapy, phase, table, rdi, secondline, efficacy, present, google, scholar, clinical, patient, versus, pubmed, iii, mgm, cas, studies, thirdline, performed, adverse, events, nivolumab, trial, medical, safety, paclitaxel, grade, japan, laterline, salvageline, platinum,
Topics {✒️}
capecitabine/cisplatin versus 5-fluorouracil/cisplatin gastro-oesophageal junction cancer gastro-esophageal junction cancer her2-positive advanced gastric tcog gi-0801/birip trial gastro-oesophageal junction adenocarcinoma advanced gastric cancer 3rd-/4th-line therapy pretreated gastric cancer high-initial dose group low-initial dose group bi-weekly administration regimen hirofumi ohmura advanced esophagogastric cancer phase iii trial metastatic gastric cancer jcho kyushu hospital rdi-high group estimated privacy choices/manage cookies related subjects fluorouracil versus combination phase iii study manageable toxicity profile cancer chemother pharmacol present cohort included estimated cancer incidence therapy-related toxicities anti-her2 therapy clinical research institute treatment-related deaths her2-positive agc patients anti-vegfr therapy salvage-line treatment suggested bi-weekly administration randomised controlled trial gastric cancer gastric cancer gastric cancer 21 prior combination chemotherapy article makiyama diffuse-type adenocarcinoma intestinal-type adenocarcinoma refractory oesophagogastric adenocarcinoma common terminology criteria author information authors japanese clinical practice advanced gastric cisplatin versus s-1 prospective clinical studies present study showed
Schema {🗺️}
WebPage:
mainEntity:
headline:Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
description:Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Medical records of AGC patients who were treated with irinotecan monotherapy as salvage-line treatment in six institutions from 2007 to 2014 were reviewed. A total of 146 patients had prior fluoropyrimidine and taxane therapies, and 75.3% had prior platinum therapy. The median age was 66 (range 27–81) years, and 102 males (69.9%) were included. Performance status (PS) was 0/1/2/3 in 53/70/19/4 patients. Eighty-nine patients (61.0%) had two or more metastatic sites. Irinotecan monotherapy as 3rd-/4th-line therapy was performed in 135/11 (92.5%/7.5%). The median number of administrations was 4 (range 1–62). Forty-six patients (31.5%) required initial dose reduction at the physician’s discretion. The overall response rate was 6.8%, and the disease control rate was 43.1%. The median PFS was 3.19 months [95% confidence interval (CI) 2.30–4.08 months], and the median OS was 6.61 months (95% CI 5.94–7.28 months). Grade 3/4 adverse events were hematological toxicity (46 patients, 31.5%) and non-hematological toxicity (50 patients, 34.2%). Hospitalization due to adverse events was required in 31 patients (21.2%). Patients with relative dose intensity (RDI) less than 80% showed similar survival to those with RDI 80% or higher. Irinotecan monotherapy was relatively safely performed as salvage-line treatment for AGC in Japanese clinical practice. Careful patient selection and intensive modification of the dose of irinotecan might possibly be associated with favorable survival.
datePublished:2017-08-10T00:00:00Z
dateModified:2017-08-10T00:00:00Z
pageStart:464
pageEnd:472
sameAs:https://doi.org/10.1007/s10120-017-0759-9
keywords:
Gastric cancer
Advanced
Chemotherapy
Irinotecan
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-017-0759-9/MediaObjects/10120_2017_759_Fig1_HTML.gif
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Akitaka Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kohei Arimizu
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Gen Hirano
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Chinatsu Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuzo Matsushita
affiliation:
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Shirakawa
affiliation:
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
type:Organization
type:Person
name:Hirofumi Ohmura
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Masato Komoda
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Keita Uchino
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kyoko Inadomi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Shuji Arita
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ariyama
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hitoshi Kusaba
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yudai Shinohara
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Miyuki Kuwayama
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tatsuhiro Kajitani
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hisanobu Oda
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Taito Esaki
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Koichi Akashi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Eishi Baba
url:http://orcid.org/0000-0001-9428-6772
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
description:Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Medical records of AGC patients who were treated with irinotecan monotherapy as salvage-line treatment in six institutions from 2007 to 2014 were reviewed. A total of 146 patients had prior fluoropyrimidine and taxane therapies, and 75.3% had prior platinum therapy. The median age was 66 (range 27–81) years, and 102 males (69.9%) were included. Performance status (PS) was 0/1/2/3 in 53/70/19/4 patients. Eighty-nine patients (61.0%) had two or more metastatic sites. Irinotecan monotherapy as 3rd-/4th-line therapy was performed in 135/11 (92.5%/7.5%). The median number of administrations was 4 (range 1–62). Forty-six patients (31.5%) required initial dose reduction at the physician’s discretion. The overall response rate was 6.8%, and the disease control rate was 43.1%. The median PFS was 3.19 months [95% confidence interval (CI) 2.30–4.08 months], and the median OS was 6.61 months (95% CI 5.94–7.28 months). Grade 3/4 adverse events were hematological toxicity (46 patients, 31.5%) and non-hematological toxicity (50 patients, 34.2%). Hospitalization due to adverse events was required in 31 patients (21.2%). Patients with relative dose intensity (RDI) less than 80% showed similar survival to those with RDI 80% or higher. Irinotecan monotherapy was relatively safely performed as salvage-line treatment for AGC in Japanese clinical practice. Careful patient selection and intensive modification of the dose of irinotecan might possibly be associated with favorable survival.
datePublished:2017-08-10T00:00:00Z
dateModified:2017-08-10T00:00:00Z
pageStart:464
pageEnd:472
sameAs:https://doi.org/10.1007/s10120-017-0759-9
keywords:
Gastric cancer
Advanced
Chemotherapy
Irinotecan
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-017-0759-9/MediaObjects/10120_2017_759_Fig1_HTML.gif
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Akitaka Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kohei Arimizu
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Gen Hirano
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Chinatsu Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuzo Matsushita
affiliation:
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Shirakawa
affiliation:
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
type:Organization
type:Person
name:Hirofumi Ohmura
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Masato Komoda
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Keita Uchino
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Kyoko Inadomi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Shuji Arita
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ariyama
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hitoshi Kusaba
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yudai Shinohara
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Miyuki Kuwayama
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Tatsuhiro Kajitani
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Hisanobu Oda
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Taito Esaki
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Koichi Akashi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
type:Person
name:Eishi Baba
url:http://orcid.org/0000-0001-9428-6772
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:21
Organization:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Akitaka Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Kohei Arimizu
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Gen Hirano
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Chinatsu Makiyama
affiliation:
name:Japan Community Healthcare Organization Kyushu Hospital
address:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Yuzo Matsushita
affiliation:
name:Hamanomachi Hospital
address:
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Tsuyoshi Shirakawa
affiliation:
name:Miyazaki Prefectural Miyazaki Hospital
address:
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
type:PostalAddress
type:Organization
name:Hirofumi Ohmura
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Masato Komoda
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Keita Uchino
affiliation:
name:National Hospital Organization Kyushu Medical Center
address:
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Kyoko Inadomi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Shuji Arita
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Hiroshi Ariyama
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Hitoshi Kusaba
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Yudai Shinohara
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Miyuki Kuwayama
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Tatsuhiro Kajitani
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Hisanobu Oda
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Saiseikai Fukuoka General Hospital
address:
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Taito Esaki
affiliation:
name:National Hospital Organization Kyushu Cancer Center
address:
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Koichi Akashi
affiliation:
name:Kyushu University
address:
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
name:Eishi Baba
url:http://orcid.org/0000-0001-9428-6772
affiliation:
name:Kyushu University
address:
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
name:Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
name:Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
name:Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Medical Oncology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
name:Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
name:Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
name:Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
External Links {🔗}(111)
- How much does https://www.springernature.com/gp/authors pull in monthly?
- How much profit is https://link.springernature.com/home/ making per month?
- What are the total earnings of https://order.springer.com/public/cart?
- How much income does https://www.editorialmanager.com/gcan have?
- What's the profit of https://orcid.org/0000-0001-9428-6772?
- How much does https://beta.springernature.com/pre-submission?journalId=10120 earn?
- Profit of http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
- How much does http://scholar.google.com/scholar_lookup?&title=Japanese%20gastric%20cancer%20treatment%20guidelines%202014%20%28ver.4%29&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-016-0622-4&volume=20&pages=1-19&publication_year=2017&author=Association%2CJapanese%20Gastric%20Cancer generate monthly?
- How much does https://doi.org/10.1016%2FS1470-2045%2808%2970035-4 rake in every month?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18282805
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=S-1%20plus%20cisplatin%20versus%20S-1%20alone%20for%20first-line%20treatment%20of%20advanced%20gastric%20cancer%20%28SPIRITS%20trial%29%3A%20a%20phase%20III%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2808%2970035-4&volume=9&pages=215-221&publication_year=2008&author=Koizumi%2CW&author=Narahara%2CH&author=Hara%2CT&author=Takagane%2CA&author=Akiya%2CT&author=Takagi%2CM?
- What's the total monthly financial gain of https://doi.org/10.1016%2FS1470-2045%2809%2970259-1?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19818685 have monthly?
- http://scholar.google.com/scholar_lookup?&title=Fluorouracil%20versus%20combination%20of%20irinotecan%20plus%20cisplatin%20versus%20S-1%20in%20metastatic%20gastric%20cancer%3A%20a%20randomised%20phase%203%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2809%2970259-1&volume=10&pages=1063-1069&publication_year=2009&author=Boku%2CN&author=Yamamoto%2CS&author=Fukuda%2CH&author=Shirao%2CK&author=Doi%2CT&author=Sawaki%2CA's financial summary
- How much revenue does https://doi.org/10.1093%2Fannonc%2Fmdn717 produce monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19153121 make?
- How much money does http://scholar.google.com/scholar_lookup?&title=Capecitabine%2Fcisplatin%20versus%205-fluorouracil%2Fcisplatin%20as%20first-line%20therapy%20in%20patients%20with%20advanced%20gastric%20cancer%3A%20a%20randomised%20phase%20III%20noninferiority%20trial&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdn717&volume=20&pages=666-673&publication_year=2009&author=Kang%2CYK&author=Kang%2CWK&author=Shin%2CDB&author=Chen%2CJ&author=Xiong%2CJ&author=Wang%2CJ generate?
- https://doi.org/10.1056%2FNEJMoa073149's total income per month
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18172173?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Capecitabine%20and%20oxaliplatin%20for%20advanced%20esophagogastric%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa073149&volume=358&pages=36-46&publication_year=2008&author=Cunningham%2CD&author=Starling%2CN&author=Rao%2CS&author=Iveson%2CT&author=Nicolson%2CM&author=Coxon%2CF?
- Earnings of https://doi.org/10.1016%2FS0140-6736%2810%2961121-X
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20728210 make?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Trastuzumab%20in%20combination%20with%20chemotherapy%20versus%20chemotherapy%20alone%20for%20treatment%20of%20HER2-positive%20advanced%20gastric%20or%20gastro-oesophageal%20junction%20cancer%20%28ToGA%29%3A%20a%20phase%203%2C%20open-label%2C%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2810%2961121-X&volume=376&pages=687-697&publication_year=2010&author=Bang%2CYJ&author=Cutsem%2CE&author=Feyereislova%2CA&author=Chung%2CHC&author=Shen%2CL&author=Sawaki%2CA?
- How much revenue does https://doi.org/10.1016%2Fj.ejca.2011.06.002 bring in?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21742485's financial summary
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Survival%20advantage%20for%20irinotecan%20versus%20best%20supportive%20care%20as%20second-line%20chemotherapy%20in%20gastric%20cancer%E2%80%94a%20randomised%20phase%20III%20study%20of%20the%20Arbeitsgemeinschaft%20Internistische%20Onkologie%20%28AIO%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2011.06.002&volume=47&pages=2306-2314&publication_year=2011&author=Thuss-Patience%2CPC&author=Kretzschmar%2CA&author=Bichev%2CD&author=Deist%2CT&author=Hinke%2CA&author=Breithaupt%2CK
- How much money does https://doi.org/10.1200%2FJCO.2011.39.4585 generate?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22412140
- How much profit does http://scholar.google.com/scholar_lookup?&title=Salvage%20chemotherapy%20for%20pretreated%20gastric%20cancer%3A%20a%20randomized%20phase%20III%20trial%20comparing%20chemotherapy%20plus%20best%20supportive%20care%20with%20best%20supportive%20care%20alone&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2011.39.4585&volume=30&pages=1513-1518&publication_year=2012&author=Kang%2CJH&author=Lee%2CSI&author=Lim%2CDH&author=Park%2CKW&author=Oh%2CSY&author=Kwon%2CHC make?
- What's the income generated by https://doi.org/10.1016%2FS1470-2045%2813%2970549-7 each month?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24332238's gross income?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Docetaxel%20versus%20active%20symptom%20control%20for%20refractory%20oesophagogastric%20adenocarcinoma%20%28COUGAR-02%29%3A%20an%20open-label%2C%20phase%203%20randomised%20controlled%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2813%2970549-7&volume=15&pages=78-86&publication_year=2014&author=Ford%2CHE&author=Marshall%2CA&author=Bridgewater%2CJA&author=Janowitz%2CT&author=Coxon%2CFY&author=Wadsley%2CJ have monthly?
- How much revenue does https://doi.org/10.1016%2FS0140-6736%2813%2961719-5 produce monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24094768 bring in?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Ramucirumab%20monotherapy%20for%20previously%20treated%20advanced%20gastric%20or%20gastro-oesophageal%20junction%20adenocarcinoma%20%28REGARD%29%3A%20an%20international%2C%20randomised%2C%20multicentre%2C%20placebo-controlled%2C%20phase%203%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2813%2961719-5&volume=383&pages=31-39&publication_year=2014&author=Fuchs%2CCS&author=Tomasek%2CJ&author=Yong%2CCJ&author=Dumitru%2CF&author=Passalacqua%2CR&author=Goswami%2CC?
- What's the profit of https://doi.org/10.1016%2FS1470-2045%2814%2970420-6?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25240821?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Ramucirumab%20plus%20paclitaxel%20versus%20placebo%20plus%20paclitaxel%20in%20patients%20with%20previously%20treated%20advanced%20gastric%20or%20gastro-oesophageal%20junction%20adenocarcinoma%20%28RAINBOW%29%3A%20a%20double-blind%2C%20randomised%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2814%2970420-6&volume=15&pages=1224-1235&publication_year=2014&author=Wilke%2CH&author=Muro%2CK&author=Cutsem%2CE&author=Oh%2CSC&author=Bodoky%2CG&author=Shimada%2CY?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8633249?
- How much income is http://scholar.google.com/scholar_lookup?&title=CPT-11%3A%20an%20original%20spectrum%20of%20clinical%20activity&journal=Semin%20Oncol&volume=23&pages=21-26&publication_year=1996&author=Rothenberg%2CML earning monthly?
- https://doi.org/10.1200%2FJCO.2012.48.5805's revenue stream
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24190112?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20open-label%2C%20phase%20III%20study%20comparing%20irinotecan%20with%20paclitaxel%20in%20patients%20with%20advanced%20gastric%20cancer%20without%20severe%20peritoneal%20metastasis%20after%20failure%20of%20prior%20combination%20chemotherapy%20using%20fluoropyrimidine%20plus%20platinum%3A%20WJOG%204007%20trial&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2012.48.5805&volume=31&pages=4438-4444&publication_year=2013&author=Hironaka%2CS&author=Ueda%2CS&author=Yasui%2CH&author=Nishina%2CT&author=Tsuda%2CM&author=Tsumura%2CT?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21340668 bring in each month?
- How much money does http://scholar.google.com/scholar_lookup?&title=Association%20of%20fluoropyrimidines%2C%20platinum%20agents%2C%20taxanes%2C%20and%20irinotecan%20in%20any%20line%20of%20chemotherapy%20with%20survival%20in%20patients%20with%20advanced%20gastric%20cancer&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-011-0019-3&volume=14&pages=155-160&publication_year=2011&author=Shitara%2CK&author=Matsuo%2CK&author=Mizota%2CA&author=Kondo%2CC&author=Nomura%2CM&author=Takahari%2CD make?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27566700 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20irinotecan%20monotherapy%20as%20third-line%20treatment%20for%20advanced%20gastric%20cancer&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-016-3138-z&volume=78&pages=809-814&publication_year=2016&author=Kawakami%2CT&author=Machida%2CN&author=Yasui%2CH&author=Kawahira%2CM&author=Kawai%2CS&author=Kito%2CY's financial summary
- How much revenue does https://doi.org/10.1016%2Fj.ejca.2014.01.020 bring in?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24560487
- Find out how much http://scholar.google.com/scholar_lookup?&title=Biweekly%20irinotecan%20plus%20cisplatin%20versus%20irinotecan%20alone%20as%20second-line%20treatment%20for%20advanced%20gastric%20cancer%3A%20a%20randomised%20phase%20III%20trial%20%28TCOG%20GI-0801%2FBIRIP%20trial%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2014.01.020&volume=50&pages=1437-1445&publication_year=2014&author=Higuchi%2CK&author=Tanabe%2CS&author=Shimada%2CK&author=Hosaka%2CH&author=Sasaki%2CE&author=Nakayama%2CN earns monthly
- https://citation-needed.springer.com/v2/references/10.1007/s10120-017-0759-9?format=refman&flavour=references income
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akitaka%20Makiyama?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akitaka%20Makiyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kohei%20Arimizu have?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kohei%20Arimizu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gen%20Hirano generate?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gen%20Hirano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chinatsu%20Makiyama?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chinatsu%20Makiyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuzo%20Matsushita?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuzo%20Matsushita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tsuyoshi%20Shirakawa generate monthly?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tsuyoshi%20Shirakawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hirofumi%20Ohmura
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hirofumi%20Ohmura%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masato%20Komoda pull in monthly?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masato%20Komoda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Keita%20Uchino
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Keita%20Uchino%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kyoko%20Inadomi?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kyoko%20Inadomi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shuji%20Arita?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shuji%20Arita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroshi%20Ariyama pull in monthly?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroshi%20Ariyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hitoshi%20Kusaba?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hitoshi%20Kusaba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yudai%20Shinohara?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yudai%20Shinohara%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Miyuki%20Kuwayama generate?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Miyuki%20Kuwayama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tatsuhiro%20Kajitani pull in?
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tatsuhiro%20Kajitani%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hisanobu%20Oda's gross income?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hisanobu%20Oda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Taito%20Esaki generate?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Taito%20Esaki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Koichi%20Akashi?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Koichi%20Akashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eishi%20Baba make?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eishi%20Baba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- Discover the revenue of https://static-content.springer.com/esm/art%3A10.1007%2Fs10120-017-0759-9/MediaObjects/10120_2017_759_MOESM1_ESM.docx
- How much does https://s100.copyright.com/AppDispatchServlet?title=Irinotecan%20monotherapy%20as%20third-line%20or%20later%20treatment%20in%20advanced%20gastric%20cancer&author=Akitaka%20Makiyama%20et%20al&contentID=10.1007%2Fs10120-017-0759-9©right=The%20International%20Gastric%20Cancer%20Association%20and%20The%20Japanese%20Gastric%20Cancer%20Association&publication=1436-3291&publicationDate=2017-08-10&publisherName=SpringerNature&orderBeanReset=true pull in monthly?
- What's the financial intake of https://crossmark.crossref.org/dialog/?doi=10.1007/s10120-017-0759-9?
- How much income is https://citation-needed.springer.com/v2/references/10.1007/s10120-017-0759-9?format=refman&flavour=citation earning monthly?
- Get to know https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's earnings
- What's the financial outcome of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- What's the income generated by https://www.springernature.com/gp/products each month?
- How much profit is https://www.springernature.com/gp/librarians making per month?
- What's https://www.springernature.com/gp/societies's gross income?
- What is the earnings of https://www.springernature.com/gp/partners?
- What are the total earnings of https://www.springer.com/?
- Earnings of https://www.nature.com/
- What's the financial intake of https://www.biomedcentral.com/?
- https://www.palgrave.com/ income
- Income figures for https://www.apress.com/
- How much does https://www.springernature.com/gp/legal/ccpa rake in every month?
- How much does https://www.springernature.com/gp/info/accessibility generate monthly?
- Income figures for https://support.springernature.com/en/support/home
- What's the profit of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How much income does https://www.springernature.com/ have?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref